Page 105 - 2023-03-中国全科医学

·354· http: //www.chinagp.net E-mail: zgqkyx@chinagp.net.cn Jaunary 2023, Vol.26 No.3

［9］NG KEE KWONG K C，MEHTA P R，SHUKLA G，et al. 3908-3917. DOI：10.1161/STROKEAHA.121.034883.
COVID-19，SARS and MERS：a neurological perspective［J］. ［24］BEKELIS K，MISSIOS S，AHMAD J，et al. Ischemic stroke
J Clin Neurosci，2020，77：13-16. DOI：10.1016/j.jocn.2020.04.124. occurs less frequently in patients with COVID-19：a multicenter
［10］KONCZ J，OROSZ V，SULYOK Z，et al. Treatment options for cross-sectional study［J］. Stroke，2020，51（12）：3570-
enormous carotid thrombus as a complication of SARS-CoV-2 3576. DOI：10.1161/STROKEAHA.120.031217.
infection［J］. Ideggyogy Sz，2021，74（3/4）：129-134. ［25］LIN C，AREVALO Y A，NANAVATI H D，et al. Racial
DOI：10.18071/isz.74.0129. differences and an increased systemic inflammatory response are
［11］BALCOM E F，NATH A，POWER C. Acute and chronic seen in patients with COVID-19 and ischemic stroke［J］. Brain
neurological disorders in COVID-19：potential mechanisms of Behav Immun Health，2020，8：100137. DOI：10.1016/j.
disease［J］. Brain，2021，144（12）：3576-3588. DOI： bbih.2020.100137.
10.1093/brain/awab302. ［26］TOPCUOGLU M A，PEKTEZEL M Y，OGE D D，et al. Stroke
［12］PAGE M J，MCKENZIE J E，BOSSUYT P M，et al. The PRISMA mechanism in COVID-19 infection：a prospective case-control
2020 statement：an updated guideline for reporting systematic study［J］. J Stroke Cerebrovasc Dis，2021，30（8）：105919.
reviews［J］. Int J Surg，2021，88：105906. DOI：10.1016/j. DOI：10.1016/j.jstrokecerebrovasdis.2021.105919.
ijsu.2021.105906. ［27］PERRY R J，SMITH C J，ROFFE C，et al. Characteristics and
［13］HOERTEL N，SÁNCHEZ-RICO M，VERNET R，et al. outcomes of COVID-19 associated stroke：a UK multicentre case-
Observational study of haloperidol in hospitalized patients with control study［J］. J Neurol Neurosurg Psychiatry，2021，92（3）：
COVID-19［J］. PLoS One，2021，16（2）：e0247122. DOI： 242-248. DOI：10.1136/jnnp-2020-324927.
10.1371/journal.pone.0247122. ［28］JOHN S，HUSSAIN S I，PIECHOWSKI-JOZWIAK B，et al.
［14］中华医学会神经病学分会，中华医学会神经病学分会脑血 Clinical characteristics and admission patterns of stroke patients
管病学组 . 中国急性缺血性脑卒中诊治指南 2018［J］. 中华 during the COVID 19 pandemic：a single center retrospective，
神 经 科 杂 志，2018，51（9）：666-682. DOI：10.3760/cma. observational study from the Abu Dhabi，United Arab
j.issn.1006-7876.2018.09.004. Emirates［J］. Clin Neurol Neurosurg，2020，199：106227.
［15］LANG S，KLEIJNEN J. Quality assessment tools for observational DOI：10.1016/j.clineuro.2020.106227.
studies：lack of consensus［J］. Int J Evid Based Healthc，2010， ［29］WANG M H，ZHANG H，HE Y Q，et al. Association between
8（4）：247. DOI：10.1111/j.1744-1609.2010.00195.x. ischemic stroke and COVID-19 in China：a population-based
［16］DHAMOON M S，THALER A，GURURANGAN K，et al. Acute retrospective study［J］. Front Med （Lausanne），2021，8：
cerebrovascular events with COVID-19 infection［J］. Stroke， 792487. DOI：10.3389/fmed.2021.792487.
2021，52（1）：48-56. DOI：10.1161/STROKEAHA.120.031668. ［30］CIOLLI L，RIGHI V，VANDELLI G，et al. In-hospital and
［17］QURESHI A I，BASKETT W I，HUANG W，et al. Acute out-of-hospital stroke in patients with COVID-19：two different
ischemic stroke and COVID-19：an analysis of 27 676 diseases? ［J］. Neurol Sci，2022，43（4）：2203-2210. DOI：
patients［J］. Stroke，2021，52（3）：905-912. DOI： 10.1007/s10072-021-05807-w.
10.1161/STROKEAHA.120.031786. ［31］GARCÍA-LAMBERECHTS E J，MIRÓ Ò，FRAGIEL M，et al.
［18］KATZ J M，LIBMAN R B，WANG J J，et al. Cerebrovascular A case-control analysis of stroke in COVID-19 patients：results of
complications of COVID-19［J］. Stroke，2020，51（9）： unusual manifestations of COVID-19-study 11［J］. Acad Emerg
e227-231. DOI：10.1161/STROKEAHA.120.031265. Med，2021，28（11）：1236-1250. DOI：10.1111/acem.14389.
［19］BHATIA R，SRIVASTAVA M V P，SYLAJA P N，et al. Clinical ［32］KVERNLAND A，KUMAR A，YAGHI S，et al. Anticoagulation
features and outcome of stroke with COVID-19. COVID-19 stroke use and hemorrhagic stroke in SARS-CoV-2 patients treated at a
study group （CSSG），India［J］. Ann Indian Acad Neurol， New York healthcare system［J］. Neurocrit Care，2021，34（3）：
2021，24（5）：668-685. DOI：10.4103/aian.AIAN_122_21. 748-759. DOI：10.1007/s12028-020-01077-0.
［20］MEHRPOUR M，SHUAIB A，FARAHANI M，et al. Coronavirus ［33］BENUSSI A，PILOTTO A，PREMI E，et al. Clinical
disease 2019 and stroke in Iran：a case series and effects on stroke characteristics and outcomes of inpatients with neurologic disease and
admissions［J］. Int J Stroke，2021，16（9）：1047-1052. COVID-19 in Brescia，Lombardy，Italy［J］. Neurology，2020，
DOI：10.1177/1747493020937397. 95（7）：e910-920. DOI：10.1212/WNL.0000000000009848.
［21］PABLO N，ISABEL R C，CECILIA R，et al. COVID-19 and ［34］STAMM B，HUANG D，ROYAN R，et al. Pathomechanisms and
ischemic stroke：clinical and neuroimaging findings［J］. treatment implications for stroke in COVID-19：a review of the
J Neuroimaging，2020，31（1）. literature［J］. Life （Basel），2022，12（2）：207. DOI：
［22］MATHEW T，JOHN S K，SARMA G，et al. COVID-19- 10.3390/life12020207.
related strokes are associated with increased mortality and ［35］YANG Q H，TONG X，COLEMAN KING S，et al. Stroke
morbidity：a multicenter comparative study from Bengaluru， hospitalizations before and during COVID-19 pandemic among
South India［J］. Int J Stroke，2021，16（4）：429-436. DOI： medicare beneficiaries in the United States［J］. Stroke，2021，52
10.1177/1747493020968236. （11）：3586-3601. DOI：10.1161/STROKEAHA.121.034562.
［23］MARTÍ-FÀBREGAS J，GUISADO-ALONSO D，DELGADO- ［36］TREJO-GABRIEL-GALÁN J M. Stroke as a complication and
MEDEROS R，et al. Impact of COVID-19 infection on the outcome prognostic factor of COVID-19［J］. Neurol Engl Ed，2020，35（5）：
of patients with ischemic stroke［J］. Stroke，2021，52（12）： 318-322. DOI：10.1016/j.nrleng.2020.04.013.